Qatar cancer centre is attracting patients from region with individualized treatment
Published: 4 February 2025
Most patients from Western countries diagnosed in Qatar prefer to receive treatment at HMC
NT Bureau
Doha
The National Center for Cancer Care and Research (NCCCR) at Hamad Medical Corporation is at the forefront of cancer treatment in Qatar and the region, setting new standards for excellence in healthcare.
By focusing on personalized, multidisciplinary care and state-of-the-art facilities, NCCCR not only deliv-ers world-class standards of care for patients in Qatar but also attracts patients from across the region.
NCCCR’s expert team collaborates to create individualized cancer treatment plans, ensuring optimal outcomes and enhancing the quality of life. This approach involves experienced oncologists, surgeons, radiologists, nurses, and allied health professionals providing comprehensive support throughout the patient’s journey.
The hospital employs advanced technology to deliver holistic care that encompasses early detection, diagnosis, treatment, survivorship, and palliative care. Timely intervention is critical; over 90 percent of suspected cancer patients at HMC are seen within 48 hours of referral – one of the fastest referral rates globally.
Dr. Mohamed Salem Al Hassan, Medical Director and CEO of NCCCR and Chair Corporate Cancer Ser-vices, HMC, commented: “HMC is a national and regional leader in cancer care, offering unique tech-nologies that set us apart. Our facilities feature advanced treatment modalities, such as robotic-assisted surgery and innovative imaging techniques, enabling precise interventions that enhance pa-tient outcomes.”
NCCCR’s advanced capabilities have been crucial in reducing the need for cancer patients in Qatar to travel abroad for further treatment. With comprehensive services and innovative treatment options, patients can effectively manage their conditions within Qatar.
Additionally, the exceptional quality and reputation of cancer care at NCCCR attract patients from across the region, including those from GCC countries, who seek treatment at the hospital annually. Most patients from Western countries diagnosed in Qatar prefer to receive oncology and hematology treatment within HMC rather than returning to their home countries.
